General
Overviews
|
|
.
|
Albertsen
PC.
What
is the risk posed by prostate cancer?
J
Natl Cancer Inst Monogr. 2012 Dec;2012(45):169-74. doi:
10.1093/jncimonographs/lgs028. Epub 2012 Sep 14.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Bolla M, Mirimanoff RO.
Prostate cancer: On the road of
progress.
Asian J Urol. 2019 Apr;6(2):123-124. doi:
10.1016/j.ajur.2019.01.002. Epub 2019 Jan 9.
Source
| Full
text |
Similar
articles
|
|
|
.>>>
Rintracciare
gli articoli
|
Bjurlin MA, Taneja SS.
Prostate Cancer.
Urol
Clin North Am. 2017 Nov;44(4):xv-xvi. doi:
10.1016/j.ucl.2017.08.001. [Editorial]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Carlaw KR, Woo HH.
Evaluation of the changing landscape
of prostate cancer diagnosis and management from 2005 to 2016.
Prostate Int. 2017 Dec;5(4):130-134. doi:
10.1016/j.prnil.2017.04.005. Epub 2017 Apr 28.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Castillejos-Molina
RA, Gabilondo-Navarro FB.
Prostate
cancer.
Salud
Publica Mex. 2016 Apr;58(2):279-84.
Source
|
Full
text |
Similar
articles
|
|
|
|
Cimadamore A, Scarpelli M, Raspollini MR, Doria A, Galosi AB,
Massari F, Di Nunno V, Cheng L, Lopez-Beltran A, Montironi R.
Prostate cancer pathology: What has changed in the last 5
years.
Urologia. 2019 Sep 23:391560319876821. doi:
10.1177/0391560319876821. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Cotter
K, Konety B, Ordonez MA.
Contemporary
Management of Prostate Cancer.
F1000Res.
2016 Feb 16;5. pii: F1000 Faculty Rev-179. doi:
10.12688/f1000research.7183.1. eCollection 2016.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Daniyal
M, Siddiqui ZA, Akram M, Asif HM, Sultana S, Khan A.
Epidemiology,
etiology, diagnosis and treatment of prostate cancer.
Asian
Pac J Cancer Prev. 2014;15(22):9575-8.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Dong DX, Ji ZG.
Current Progress and Controversies in
Prostate Cancer Management.
Chin Med J (Engl). 2017 Dec
20;130(24):2991-2995. doi: 10.4103/0366-6999.220317 .
Source
| Full
text |
Similar
articles
|
|
|
.
|
Glina
S, Pasternak J.
Prostate
cancer: what is the right message?
Einstein
(Sao Paulo). 2015 Dec;13(4):7-8. doi:
10.1590/S1679-45082015ED3595. [Editorial]
Source
|
Full
text |
Similar
articles
|
|
|
.*
|
Groeben C, Wirth MP.
Prostate cancer: Basics on clinical
appearance, diagnostics and treatment.
Med Monatsschr
Pharm. 2017 May;40(5):192-201. English, German.
Source
|
Abstract
|
Similar
articles
|
|
|
.
|
Grozescu
T, Popa F.
Prostate
cancer between prognosis and adequate/proper therapy.
J
Med Life. 2017 Jan-Mar;10(1):5-12.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Kibel
AS.
Intermediate
Risk Prostate Cancer and Active Surveillance: Maximize Utilization
while Minimizing Failure.
J
Urol. 2017 Jun 16. pii: S0022-5347(17)74842-2. doi:
10.1016/j.juro.2017.06.055. [Epub ahead of print]
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Kim EH, Andriole GL.
Prostate Cancer Review.
Mo
Med. 2018 Mar-Apr;115(2):131. [Editorial]
Source
[Full issue online] |
Full
text |
Similar
articles
|
|
|
.
|
Litwin
MS, Tan HJ.
The
Diagnosis and Treatment of Prostate Cancer: A Review.
JAMA.
2017 Jun 27;317(24):2532-2542. doi: 10.1001/jama.2017.7248.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Matulewicz RS, Weiner AB, Schaeffer EM.
Active
Surveillance for Prostate Cancer.
JAMA. 2017 Dec
5;318(21):2152. doi: 10.1001/jama.2017.17222.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Pollock
PA, Ludgate A, Wassersug RJ.
In
2124, half of all men can count on developing prostate cancer.
Current
Oncology, Vol. 22, No.1, February 2015.
Source
| Full
text | Similar
articles
|
|
|
.
|
Schatten H.
Brief Overview of Prostate Cancer Statistics,
Grading, Diagnosis and Treatment Strategies.
Adv Exp Med
Biol. 2018;1095:1-14. doi: 10.1007/978-3-319-95693-0_1. First
Online: 19 September 2018.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Weiner AB, Kundu SD.
Prostate Cancer: A Contemporary
Approach to Treatment and Outcomes.
Med Clin North Am.
2018 Mar;102(2):215-229. doi: 10.1016/j.mcna.2017.10.001. Epub
2017 Dec 24.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Zhuang
L, Johnson MT.
How
Precisely Can Prostate Cancer Be Managed?
Int
Neurourol J. 2016 Nov;20(Suppl 2):S120-130. Epub 2016 Nov 22.
Source
|
Full
text |
Similar
articles
|
|
|
USING
PROGNOSIS TO GUIDE EARLY DETECTION AND TREATMENT
|
|
.
|
Gnanapragasam VJ, Barrett T, Massie C, Pacey S, Warren A.
Using
prognosis to guide early detection and treatment selection in
non-metastatic prostate cancer.
BJU Int. 2018
Nov 30. doi: 10.1111/bju.14637. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
ASCO
ANNUAL REPORTS ON CLINICAL ADVANCES
|
|
.
|
Heymach J, Krilov L, Alberg A, Baxter N, Chang SM, Corcoran R,
Dale W, DeMichele A, Magid Diefenbach CS, Dreicer R, Epstein AS,
Gillison ML, Graham DL, Jones J, Ko AH, Lopez AM, Maki RG,
Rodriguez-Galindo C, Schilsky RL, Sznol M, Westin SN, Burstein H.
Clinical Cancer Advances 2018: Annual Report on Progress
Against Cancer From the American Society of Clinical Oncology.
J Clin Oncol. 2018 Apr 1;36(10):1020-1044. doi:
10.1200/JCO.2017.77.0446. Epub 2018 Jan 30.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Burstein HJ, Krilov L, Aragon-Ching JB, Baxter NN, Chiorean EG,
Chow WA, De Groot JF, Devine SM, DuBois SG, El-Deiry WS, Epstein
AS, Heymach J, Jones JA, Mayer DK, Miksad RA, Pennell NA, Sabel
MS, Schilsky RL, Schuchter LM, Tung N, Winkfield KM, Wirth LJ,
Dizon DS.
Clinical Cancer Advances 2017: Annual Report on
Progress Against Cancer From the American Society of Clinical
Oncology.
J Clin
Oncol. 2017 Apr 20;35(12):1341-1367. doi:
10.1200/JCO.2016.71.5292. Epub 2017 Feb 1.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Roth BJ,
Krilov L, Adams S, Aghajanian CA, Bach P, Braiteh F, Brose MS,
Ellis LM, Erba H, George DJ, Gilbert MR, Jacobson JO, Larsen EC,
Lichtman SM, Partridge AH, Patel JD, Quinn DI, Robison LL, von
Roenn JH, Samlowski W, Schwartz GK, Vogelzang NJ.
Clinical
cancer advances 2012: annual report on progress against cancer
from the american society of clinical oncology.
J
Clin Oncol. 2013 Jan 1;31(1):131-61. doi:
10.1200/JCO.2012.47.1938. Epub 2012 Dec 3
Source
| Full
text |
Erratum
|
Similar
articles
|
|
|
.
|
Vogelzang
NJ, Benowitz SI, Adams S, Aghajanian C, Chang SM, Dreyer ZE, Janne
PA, Ko AH, Masters GA, Odenike O, Patel JD, Roth BJ, Samlowski WE,
Seidman AD, Tap WD, Temel JS, Von Roenn JH, Kris MG.
Clinical
cancer advances 2011: Annual Report on Progress Against Cancer
from the American Society of Clinical Oncology.
J
Clin Oncol. 2012 Jan 1;30(1):88-109. doi:
10.1200/JCO.2011.40.1919. Epub 2011 Dec 5.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Winer E,
Gralow J, Diller L, Karlan B, Loehrer P, Pierce L, Demetri G, Ganz
P, Kramer B, Kris M, Markman M, Mayer R, Pfister D, Raghavan D,
Ramsey S, Reaman G, Sandler H, Sawaya R, Schuchter L, Sweetenham
J, Vahdat L, Schilsky RL; American Society of Clinical Oncology.
Clinical
cancer advances 2008: major research advances in cancer treatment,
prevention, and screening--a report from the American Society of
Clinical Oncology.
J
Clin Oncol. 2009 Feb 10;27(5):812-26. doi:
10.1200/JCO.2008.21.2134. Epub 2008 Dec 22. Erratum
in: J
Clin Oncol. 2009 Jun 20;27(18):3070-1.
Source
| Full
text |
Erratum
|
Similar
articles
|
|
|
Overviews
by treatment
|
|
|
Gilligan T, et al., PDQ Adult Treatment Editorial Board.
Prostate
Cancer Treatment (PDQ®): Health Professional Version.
PDQ
Cancer Information Summaries [Internet]. Bethesda (MD): National
Cancer Institute (US); 2019 Sep 20.
Source
.
Similar
articles
|
|
|
.
|
Muggia FM et al, PDQ Adult Treatment Editorial Board.
Prostate
Cancer Treatment (PDQ®): Health
Professional Version.
PDQ
Cancer Information Summaries [Internet]. Bethesda (MD): National
Cancer Institute (US); 2019 Feb 5.
Source
|
Sections
| Book
|
Similar
articles
|
|
|
.
|
Muggia FM et al, PDQ Adult Treatment Editorial Board.
Prostate
Cancer Treatment (PDQ®): Patient Version.
PDQ Cancer
Information Summaries [Internet]. Bethesda (MD): National Cancer
Institute (US); 2019 Jan 10.
Source
|
Sections
| Book
|
Similar
articles
|
|
|
ACTIVE
SURVEILLANCE
|
|
.
|
Witherspoon L, Breau RH, Lavallée LT.
Evidence-based
approach to active surveillance of prostate cancer.
World
J Urol. 2019 Feb 6. doi: 10.1007/s00345-019-02662-5. [Epub ahead
of print]
Source
| Full
text |
Similar
articles
|
|
|
FOCAL
THERAPY
|
|
.
|
Eggener S.
Focal Therapy for Localized Prostate Cancer.
Rev Urol. 2018;20(4):143-144. doi: 10.3909/riu0823.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Lepor H, Gold S, Wysock J.
Focal Ablation of Prostate
Cancer.
Rev Urol. 2018;20(4):145-157. doi:
10.3909/riu0809.
Source
| Full
text |
Similar
articles
|
|
|
PRECISION
MEDICINE
|
|
|
Malik A, Srinivasan S, Batra J.
A New Era of Prostate
Cancer Precision Medicine.
Front Oncol. 2019 Nov
26;9:1263. doi: 10.3389/fonc.2019.01263.
Source
/ Similar
articles .
|
|
|
THERANOSTICS
|
|
|
Ahmadzadehfar H, Rahbar K, Essler M, Biersack HJ.
PSMA-Based
Theranostics: A Step-by-Step Practical Approach to Diagnosis and
Therapy for mCRPC Patients.
Semin Nucl Med. 2020
Jan;50(1):98-109. doi: 10.1053/j.semnuclmed.2019.07.003. Epub 2019
Aug 21.
Source
/ Similar
articles .
|
|
|
Overviews
by type of cancer
|
|
|
|
FAMILIAL
PROSTATE CANCER
|
|
.
|
Giri
VN, Beebe-Dimmer JL.
Familial
prostate cancer.
Semin
Oncol. 2016 Oct;43(5):560-565. doi:
10.1053/j.seminoncol.2016.08.001. Epub 2016 Aug 18.
Source
|
Full
text |
Similar
articles
|
|
|
HIGH-RISK
(ADVANCED) PROSTATE CANCER
|
|
.
|
Campobasso D, Prati G, Frattini A.
Very high-risk
prostate cancer: multimodality treatment will be the new frontier.
Cent European J Urol. 2017;70(3):324-325. doi:
10.5173/ceju.2017.1535. Epub 2017 Aug 16.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Faiena I, Kim IY, Jang TL.
Multimodal treatments for
advanced prostate cancer.
Oncotarget. 2019 Jan
8;10(3):255-256. doi: 10.18632/oncotarget.26525. eCollection 2019
Jan 8.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Fonteyne V, Ost P.
Current Insights in the Management of
High-risk Prostate Cancer: Still More Questions than Answers.
Eur
Urol. 2018 Aug 30. pii: S0302-2838(18)30598-0. doi:
10.1016/j.eururo.2018.08.013. [Epub ahead of print]
Source
| Full
text |
Similar
articles
Comment
on: Tosco L et al, Systematic Review of Systemic Therapies and
Therapeutic Combinations with Local Treatments for High-risk
Localized Prostate Cancer. (Eur Urol. 2018 Oct 1).
|
|
|
.
|
Komura K, Sweeney CJ, Inamoto T, Ibuki N, Azuma H, Kantoff PW.
Current treatment strategies for advanced prostate
cancer.
Int J Urol. 2017 Dec 20. doi: 10.1111/iju.13512.
[Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Lee CH, Kantoff P.
Treatment of Metastatic Prostate
Cancer in 2018.
JAMA Oncol. 2018 Dec 27. doi:
10.1001/jamaoncol.2018.5621. [Epub ahead of print]
Opinion
Source
| Full
text |
Similar
articles
|
|
|
.
|
Mossanen M, Krasnow RE, Nguyen PL, Trinh QD, Preston M, Kibel AS.
Approach to the Patient with
High-Risk Prostate Cancer.
Urol Clin North Am.
2017 Nov;44(4):635-645. doi: 10.1016/j.ucl.2017.07.009.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Shah H, Vaishampayan U.
Therapy of Advanced Prostate
Cancer: Targeting the Androgen Receptor Axis in Earlier Lines of
Treatment.
Target Oncol. 2018 Dec;13(6):679-689. doi:
10.1007/s11523-018-0611-0. First Online: 07 December 2018
Source
| Full
text |
Similar
articles
|
|
|
.
|
Sumanasuriya S, De Bono J.
Treatment of Advanced Prostate
Cancer-A Review of Current Therapies and Future Promise.
Cold
Spring Harb Perspect Med. 2017 Nov 3. pii: a030635. doi:
10.1101/cshperspect.a030635. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Thomas TS, Pachynski RK.
Treatment of Advanced Prostate
Cancer.
Mo Med. 2018 Mar-Apr;115(2):156-161.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Tosco L, Briganti A, D'amico AV, Eastham J, Eisenberger M, Gleave
M, Haustermans K, Logothetis CJ, Saad F, Sweeney C, Taplin ME,
Fizazi K.
Systematic Review of Systemic Therapies and
Therapeutic Combinations with Local Treatments for High-risk
Localized Prostate Cancer.
Eur Urol. 2018 Oct 1. pii:
S0302-2838(18)30549-9. doi: 10.1016/j.eururo.2018.07.027. [Epub
ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
INTRADUCTAL
CARCINOMA OF THE PROSTATE
|
|
.
|
Kristiansen
G, Varma M, Seitz G.
[Intraductal
carcinoma of the prostate].
Pathologe.
2016 Jan 18. [Epub ahead of print] German.
Source
|
Full
text |
Similar
articles
|
|
|
LYMPH
NODE METASTASES
|
|
.
|
Bernstein AN, Shoag JE, Golan R, Halpern JA, Schaeffer EM, Hsu WC,
Nguyen PL, Sedrakyan A, Chen RC, Eggener SE, Hu JC.
Contemporary
Incidence & Outcomes of Prostate Cancer Lymph Node Metastases.
J Urol. 2017 Dec 26. pii: S0022-5347(17)78181-5. doi:
10.1016/j.juro.2017.12.048. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
LOCALIZED
PROSTATE CANCER
|
|
|
|
ADVANCES
|
|
.
|
Kapoor
A, Hotte SJ.
Localized
prostate cancer.
Can
Urol Assoc J. 2016 Aug;10(7-8Suppl3):S138-S139.
Source
|
Full
text |
Similar
articles
|
|
|
LOCALIZED
HIGH-RISK PROSTATE CANCER
|
|
.
|
Weiner
AB, Matulewicz RS, Schaeffer EM, Liauw SL, Feinglass JM, Eggener
SE.
Contemporary
management of men with high-risk localized prostate cancer in the
United States.
Prostate
Cancer Prostatic Dis. 2017 Jun 20. doi: 10.1038/pcan.2017.5. [Epub
ahead of print]
Source
|
Full
text |
Similar
articles
|
|
|
LOCALIZED
LOW-RISK PROSTATE CANCER
|
|
.
|
D'Amico
AV.
Future
of treatment for low-risk prostate cancer: for all, for some, or
for none?
J
Clin Oncol. 2011 May 20;29(15):1940-3. doi:
10.1200/JCO.2010.34.2006. Epub 2011 Apr 4.
Comment
on: Boike TP, et al, Phase I dose-escalation study of stereotactic
body radiation therapy for low- and intermediate-risk prostate
cancer. [J Clin Oncol. 2011 May 20;29(15):2020-6. doi:
10.1200/JCO.2010.31.4377. Epub 2011 Apr 4.]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Moschini
M, Carroll PR, Eggener SE, Epstein JI, Graefen M, Montironi R,
Parker C.
Low-risk
Prostate Cancer: Identification, Management, and Outcomes.
Eur
Urol. 2017 Mar 15. pii: S0302-2838(17)30174-4. doi:
10.1016/j.eururo.2017.03.009. [Epub ahead of print]
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Pruthi
DK, Ankerst DP, Liss MA.
Novel
Definitions of Low-risk and High-risk Prostate Cancer:
Implications for the European Randomized Study of Screening for
Prostate Cancer Risk Assessment Tool.
Eur
Urol. 2017 Feb 17. pii: S0302-2838(17)30098-2. doi:
10.1016/j.eururo.2017.02.009. [Epub ahead of print]
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Roobol
MJ, Verbeek JF, van der Kwast T, Kümmerlin IP, Kweldam CF,
van Leenders GJ.
Improving
the Rotterdam European Randomized Study of Screening for Prostate
Cancer Risk Calculator for Initial Prostate Biopsy by
Incorporating the 2014 International Society of Urological
Pathology Gleason Grading and Cribriform growth.
Eur
Urol. 2017 Feb 2. pii: S0302-2838(17)30058-1. doi:
10.1016/j.eururo.2017.01.033. [Epub ahead of print]
Source
|
Full
text |
Similar
articles
|
|
|
LOCALLY
ADVANCED PROSTATE CANCER
|
|
.
|
Peinemann
F, Pinkawa M.
Treatment
of locally advanced prostate cancer: a case report and narrative
review.
Case
Rep Urol. 2012;2012:402513. doi: 10.1155/2012/402513. Epub 2012
Dec 17.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Ranasinghe WKB, Reichard CA, Bathala T, Chapin BF.
Management
of cT4 Prostate Cancer.
Eur Urol Focus. 2019 Jun 29.
pii: S2405-4569(19)30167-1. doi: 10.1016/j.euf.2019.06.012. [Epub
ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
MANAGEMENT
OF BCR
|
|
.
|
Paller
CJ, Antonarakis ES.
Management
of biochemically recurrent prostate cancer after local therapy:
evolving standards of care and new directions.
Clin
Adv Hematol Oncol. 2013 Jan;11(1):14-23.
Source
| Full
text |
Similar
articles
|
|
|
METASTATIC
PROSTATE CANCER
|
|
.
|
Damodaran S, Kyriakopoulos CE, Jarrard DF.
Newly
Diagnosed Metastatic Prostate Cancer: Has the Paradigm Changed?
Urol Clin North Am. 2017 Nov;44(4):611-621. doi:
10.1016/j.ucl.2017.07.008.
Source
| Full
text |
Similar
articles
|
|
|
|
Ganau M, Gallinaro P, Cebula H, Scibilia A, Todeschi J, Gubian A,
Nannavecchia B, Signorelli F, Pop R, Coca HA, Proust F, Chibbaro
S.
Intracranial Metastases from Prostate Carcinoma:
Classification, Management, and Prognostication.
World
Neurosurg. 2019 Oct 31. doi: 10.1016/j.wneu.2019.10.125. [Epub
ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Gilson
C, Manickavasagar T. Chowdhury S.
Treatment
of metastatic prostate cancer
Trends
in Urology & Men’s Health, Vol. 6 Issue 4 Jul/Aug 2015,
Available online July 21, 2015.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Riihimäki M, Thomsen H, Sundquist K, Sundquist J, Hemminki K.
Clinical landscape of cancer metastases.
Cancer
Med. 2018 Oct 16. doi: 10.1002/cam4.1697. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Sartor O, de Bono JS.
Metastatic Prostate Cancer.
N
Engl J Med. 2018 Feb 15;378(7):645-657. doi:
10.1056/NEJMra1701695. Epub 2018 Feb 7.
Source
| Full
text |
Similar
articles
|
|
|
METASTATIC
CASTRATION RESISTANT PROSTATE CANCER
|
|
.
|
Dong L, Zieren RC, Xue W, de Reijke TM, Pienta KJ.
Metastatic
prostate cancer remains incurable, why?
Asian J Urol.
2019 Jan;6(1):26-41. doi: 10.1016/j.ajur.2018.11.005. Epub 2018
Nov 29.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Kapoor
A, Hotte SJ.
Androgen
receptor axis-targeted agents
Can
Urol Assoc J. 2016 Aug; 10(7-8Suppl3): S146–S148
Source
|
Full
text
|
|
|
.
|
Kapoor
A,
Hotte SJ.
Radionuclides.
Can
Urol Assoc J. 2016 Aug;10(7-8Suppl3):S144-S145.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Ritch
CR, Cookson MS.
Advances
in the management of castration resistant prostate cancer.
BMJ.
2016 Oct 17;355:i4405. doi: 10.1136/bmj.i4405.
Source
|
Full
text |
Similar
articles
|
|
|
METASTATIC
HORMONE-SENSITIVE PROSTATE CANCER
|
|
.
|
Bernard
B, Sweeney CJ.
Management
of metastatic hormone-sensitive prostate cancer.
Curr
Urol Rep. 2015 Mar;16(3):14. doi: 10.1007/s11934-015-0488-8. Epub
2015 Feb 13.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Kapoor
A, Hotte SJ.
Chemotherapy
research for metastatic prostate cancer.
Can
Urol Assoc J. 2016 Aug;10(7-8Suppl3):S140-S143.
Source
|
Full
text |
Similar
articles
|
|
|
NON
METASTATIC CASTRATION RESISTANT PROSTATE CANCER
|
|
.
|
Cancian M, Renzulli JF 2nd.
Non Metastatic Castration
Resistant Prostate Cancer: a Modern Perspective.
Urology.
2018 Jan 31. pii: S0090-4295(18)30044-X. doi:
10.1016/j.urology.2018.01.010. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
|
Hess-Busch Y, Hadaschik B, Hess J.
M0CRPC overview of
management options.
World J Urol. 2019 Nov 5. doi:
10.1007/s00345-019-02997-z. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Mateo J, Fizazi K, Gillessen S, Heidenreich A, Perez-Lopez R, Oyen
WJG, Shore N, Smith M, Sweeney C, Tombal B, Tomlins SA, de Bono
JS.
Managing Nonmetastatic Castration-resistant Prostate
Cancer.
Eur Urol. 2018 Aug 14. pii:
S0302-2838(18)30557-8. doi: 10.1016/j.eururo.2018.07.035. [Epub
ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
OLIGOMETASTATIC
PROSTATE CANCER
|
|
.
|
Esther J, Maughan BL, Anderson
N, Agarwal N, Hahn AW.
Management of Nonmetastatic
Castration-Resistant Prostate Cancer: Recent Advances and Future
Direction.
Curr Treat Options Oncol. 2019 Feb
11;20(2):14. doi: 10.1007/s11864-019-0611-z.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Kothari G, Ost P, Cheung P, Blanchard P, Tree AC, van As NJ, Lo
SS, Moghanaki D, Loblaw A, Siva S.
Trends in Management
of Oligometastatic Hormone-Sensitive Prostate Cancer.
Curr
Oncol Rep. 2019 Mar 27;21(5):43. doi: 10.1007/s11912-019-0791-5.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Lancia A, Zilli T, Achard V, Dirix P, Everaerts W, Gomez-Iturriaga
A, Ingrosso G, Liefhooghe N, Miralbell R, Siva S, Van der Eecken
K, Ost P.
Oligometastatic prostate cancer: The game is
afoot.
Cancer Treat Rev. 2019 Feb;73:84-90. doi:
10.1016/j.ctrv.2019.01.005. Epub 2019 Jan 17.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Nair R, Lamb BW, Geurts N, Alghazo O, Lam W, Lawrentschuk N,
Murphy DG.
The Role of Local Therapy for Oligometastatic
Prostate Cancer: Should We Expect a Cure?
Urol Clin
North Am. 2017 Nov;44(4):623-633. doi: 10.1016/j.ucl.2017.07.013.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Slaoui A, Albisinni S, Aoun F, Assenmacher G, Al Hajj Obeid W,
Diamand R, Regragui S, Touzani A, Bakar A, Mesfioui A, Karmouni T,
Ameur A, Elkhader K, Koutani A, Ibnattya A, Roumeguere T, Peltier
A.
A systematic review of contemporary management of
oligometastatic prostate cancer: fighting a challenge or tilting
at windmills?
World J Urol. 2019 Jan 31. doi:
10.1007/s00345-019-02652-7. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Stevens
DJ, Sooriakumaran P.
Oligometastatic
Prostate Cancer.
Curr
Treat Options Oncol. 2016 Dec;17(12):62. Epub 2016 Oct 27.
Source
|
Full
text |
Similar
articles
|
|
|
PROSTATE
SARCOMAS
|
|
.
|
Sohn M,
Kwon T, Jeong IG, Hong S, You D, Hong JH, Ahn H, Kim
CS.
Histologic
variability and diverse oncologic outcomes of prostate sarcomas.
Korean
J Urol. 2014 Dec;55(12):797-801. doi: 10.4111/kju.2014.55.12.797.
Epub 2014 Nov 28.
Source
| Full
text |
Similar
articles
|
|
|
Miscellanea
|
|
|
|
ALZHEIMER'S
DISEASE
|
|
.
|
Alzheimer's
Association.
2016
Alzheimer's disease facts and figures.
Alzheimers
Dement. 2016 Apr;12(4):459-509.
Source
|
Full
text |
Similar
articles
|
|
|
PSMA
|
|
.
|
Donin NM, Reiter R.
Why targeting PSMA is a game changer
in the management of prostate cancer - a Urologist's point of
view.
J Nucl Med. 2017 Oct 6. pii: jnumed.117.191874.
doi: 10.2967/jnumed.117.191874. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Zaman MU, Fatima N, Zaman A, Sajid M, Zaman U, Zaman S.
Diagnostic Challenges in Prostate
Cancer and 68Ga-PSMA PET Imaging: A Game Changer?
Asian
Pac J Cancer Prev. 2017 Oct 26;18(10):2625-2628.
Source
| Full
text |
Similar
articles
|
THERANOSTICS
|
|
.
|
Virgolini I, Decristoforo C, Haug A, Fanti S, Uprimny C.
Current
status of theranostics in prostate cancer.
Eur J Nucl
Med Mol Imaging. 2018 Mar;45(3):471-495. doi:
10.1007/s00259-017-3882-2. Epub 2017 Dec 28.
Source
| Full
text |
Similar
articles
|
|
|
SURVIVORS
|
|
.
|
Peterson
AC.
Special
concerns for survivors of prostate cancer.
Clin
Adv Hematol Oncol. 2016 Sep;14(9):674-6.
Source
|
Full
text |
Similar
articles
|
|
|
STATE
OF THE ART
|
|
.
|
Armstrong AJ.
Updates in advanced prostate cancer 2018.
Prostate Cancer Prostatic Dis. 2018 Oct 2. doi:
10.1038/s41391-018-0100-7. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Chaitoff A, Killeen TC, Nielsen C.
Men's health 2018:
BPH, prostate cancer, erectile dysfunction,
supplements.
Cleve Clin J Med. 2018
Nov;85(11):871-880. doi: 10.3949/ccjm.85a.18011. Review. Erratum
in: Cleve
Clin J Med. 2018
Dec;85(12):913.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Shen MM, Rubin MA.
Prostate Cancer Research at the
Crossroads.
Cold Spring Harb Perspect Med. 2018 Oct 22.
pii: a036277. doi: 10.1101/cshperspect.a036277. [Epub ahead of
print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Small
EJ, de Bono JS.
Prostate
cancer: evolution or revolution?
J
Clin Oncol. 2011 Sep 20;29(27):3595-8. doi:
10.1200/JCO.2011.37.8653. Epub 2011 Aug 22.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Small
EJ, Klein EA.
Challenges
and Future Directions in the Prevention and Management of Prostate
Cancer
JCO
November 10, 2005 vol. 23 no. 32 8143-8145. doi:
10.1200/JCO.2005.10.001
Source
| Full
text
|
|
|
.
|
Sternberg
CN, Beltran H.
Prostate
cancer in 2016: Improved outcomes and precision medicine come
within reach.
Nat
Rev Urol. 2017 Feb;14(2):71-72. doi: 10.1038/nrurol.2016.270. Epub
2017 Jan 4.
Source
|
Full
text |
Similar
articles
|
|
|
TREATMENT
REGISTRY
|
|
.
|
Penson
DF, Lin DW, Karsh L, Quinn DI, Shevrin DH, Shore N, Symanowski JT,
Brown B, Forer D, Wong EK, Flanders SC.
Treatment
registry for outcomes in patients with castration-resistant
prostate cancer (TRUMPET): a methodology for real-world evidence
and research.
Future
Oncol. 2016 Aug 16. [Epub ahead of print]
Source
|
Full
text |
Similar
articles
|
|
|
WAITING
TIME
|
|
.
|
Osowiecka K, Nawrocki S, Kurowicki M, Rucinska M.
The
Waiting Time of Prostate Cancer Patients in Poland.
Int
J Environ Res Public Health. 2019 Jan 26;16(3). pii: E342. doi:
10.3390/ijerph16030342.
Source
| Full
text |
Similar
articles
|
|
|
YOUNG
PATIENTS
|
|
.
|
Pompe RS, Smith A, Bandini M, Marchioni M, Martel T, Preisser F,
Leyh-Bannurah SR, Schiffmann J, Saad F, Huland H, Graefen M,
Shariat SF, Tilki D, Karakiewicz PI.
Tumor
characteristics, treatments, and oncological outcomes of prostate
cancer in men aged ≤50 years: a population-based study.
Prostate Cancer Prostatic Dis. 2018 Jan 16. doi:
10.1038/s41391-017-0006-9. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
Controversies
|
|
|
|
FASTER
DRUG APPROVALS
|
|
.
|
Parikh RB, Prasad V.
Metastasis-Free Survival in Prostate
Cancer: Faster Drug Approvals, Better Drugs?
J Clin
Oncol. 2018 Dec 11:JCO1801092. doi: 10.1200/JCO.18.01092. [Epub
ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
OLIGOMETASTATIC
PROSTATE CANCER
|
|
.
|
James ND.
Oligometastatic Prostate Cancer Should Be
Studied and Treated Differently to High-volume Disease. Con: The
Underlying Biology is the Same, so They Should Not Be Treated
Differently.
Eur Urol Focus. 2019 Feb 22. pii:
S2405-4569(19)30021-5. doi: 10.1016/j.euf.2019.01.018. [Epub ahead
of print]
Source
| Full
text |
Similar
articles
|
|
|
|
|
|
|
